Sastasundar Ventures Limited has informed the Exchange about Investor Presentation
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures submitted its August 2025 investor presentation to the exchanges, sharing Q1 FY26 and full-year FY25 financial details. Q1 FY26 revenue from operations grew 5.9% YoY to Rs 278.5 Cr, with gross profit of Rs 20.9 Cr (7.5% margin). However, EBITDA remained negative at Rs (13.8) Cr, and PAT stood at Rs 26.6 Cr (down from Rs 41 Cr YoY). Full-year FY25 revenue declined 19.7% to Rs 1,088.5 Cr with a loss of Rs 133.5 Cr. The business mix has shifted sharply toward the B2B RetailerShakti vertical (Rs 244.5 Cr in Q1) from B2C SastaSundar (Rs 33.3 Cr). The company highlighted zero borrowings, Rs 655 Cr in liquid assets, and a 12% YoY improvement in working capital days.
Mixed signals for shareholders: top-line growth returning in Q1 FY26 is positive, but persistent EBITDA losses, a sharp drop in full-year FY25 revenue and a large annual loss raise concerns about profitability. Strong liquidity and zero debt provide a cushion, but no clear margin recovery roadmap is visible in the presentation.